Riskpilot← Back to searchSign inGet full accessAPOTEK ENSJØ AS
ASActiveOrg 998002516Gladengveien 4, 0661 OsloRetail sale of pharmaceutical products · NACE 4773Est. 201211 employees
Revenue 2024
NOK 24,4M
+26% vs 2023
EBITDA margin
3.2%
+20% vs 2023
Equity ratio
46.3%
Financial strength
Net profit 2024
NOK 573K
+29% vs 2023
| Revenue | NOK 24,4M | +26% |
| EBITDA | NOK 791K | +20% |
| Net profit | NOK 573K | +29% |
| Total assets | NOK 7,3M | -15% |
| Equity | NOK 3,4M | +21% |
| Employees | 11 | — |
Legal name
APOTEK ENSJØ AS
Org number
998002516
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
21. februar 2012
Share capital
NOK 30 000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Selskapets formål er salg av legemidler og andre produkter som naturlig faller sammen med dette.
Address
Gladengveien 4, 0661 Oslo
Phone
+4722666650
Email
kontakt@apotek1.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 14 101 | 15 264 | 15 293 | 19 263 | 24 356 |
| Staff expenses | −1 954 | −2 103 | −2 257 | −2 829 | −3 677 |
| EBITDA | 1 347 | 1 525 | 664 | 660 | 791 |
| Depreciation & amort. | −67 | −81 | −92 | −71 | −53 |
| EBIT | 1 280 | 1 444 | 572 | 589 | 737 |
| Net financials | −5 | −1 | −1 | −5 | −4 |
| Profit before tax | 1 275 | 1 444 | 572 | 584 | 734 |
| Tax | 281 | 332 | 132 | 139 | 160 |
| Net profit | 995 | 1 112 | 440 | 445 | 573 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 005 | 5 584 | 5 976 | 8 536 | 7 252 |
| Equity | 1 271 | 2 383 | 2 783 | 2 784 | 3 357 |
| Long-term debt | 8 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 725 | 3 201 | 3 193 | 5 751 | 3 895 |
| Total debt | 2 734 | 3 201 | 3 193 | 5 751 | 3 895 |
EBITDA margin
3.2%
This company
15.8%
Market median
-80% vs market
20202024
Equity ratio
46.3%
This company
38.2%
Market median
+21% vs market
20202024
Return on equity
17.1%
This company
18.4%
Market median
+7% vs market
20202024
Net profit margin
2.4%
This company
8.1%
Market median
-70% vs market
20202024
Asset turnover
3.36×
This company
1.12×
Market median
+200% vs market
20202024
Debt / equity
1.16×
This company
0.62×
Market median
-87% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
VC Chief Executive Officer | Chief Executive Officer | 2012 |
TT Deputy Member | Deputy Member | 2012 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nguyen-Doan Holding As
APOTEK ENSJØ AS Board members of APOTEK ENSJØ AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vincent Cuong Nguyen-Doan | Chief Executive Officer | 0 companies |
| Therese Thu Huynh | Deputy Member | 0 companies |